Tuba Kockar Kizilirmak, MD
InstructorCards
Education
Istanbul University School of Medicine (2006)
About
Titles
Instructor
Biography
Tuba Kockar Kizilirmak is a graduate of the Istanbul University Faculty of Medicine. She completed her training in residency in pediatrics, and fellowship in pediatric pulmonology in Istanbul, Türkiye. Afterward, she relocated to the United States following her aspiration of becoming a physician-scientist. She served as a research specialist at the University of Arizona. She focused on epidemiologic studies of childhood asthma to identify early life determinants of childhood asthma by utilizing data from the Tucson Children's Study cohort.
Currently, Dr. Kizilirmak is completing an additional pediatric pulmonary fellowship at Yale University, aiming to become a well-rounded physician-scientist. Her primary research interest focuses on airway inflammation in pediatric respiratory diseases, particularly in cystic fibrosis (CF). She has presented her work at both national and international conferences. During this fellowship, she was also selected for the Pediatric Scientist Development Program (PSDP) Research Fellowship. She has received multiple awards from the Cystic Fibrosis Foundation (CFF), including first and second-year fellowship awards, the PSDP CFF fellow, and now the CFF fourth-year fellowship award. She has also been awarded an internal grant, the Yale Pediatric Scholar Award.
Her long-term goal is to gain insights into the molecular mechanisms underlying airway inflammation in CF, which may lead to developing new therapeutic options. Dr. Kizilirmak is dedicated and passionate about providing the best possible care to children with respiratory diseases nationally and globally.
Education & Training
- MD
- Istanbul University School of Medicine (2006)
Research
Research at a Glance
Yale Co-Authors
Publications Timeline
Clemente Britto-Leon, MD
Eliaz Brumer, MD
Marie Egan, MD
Alannah Garrison
Beverley Sheares, MD, MS
Emanuela Bruscia, PhD
Publications
2024
Understanding Impact of CFTR Dysfunction on Airway Immune Cell Composition in Early Lung Disease Pathogenesis
Kockar Kizilirmak T, Yin H, Garrison A, Bruscia E, Egan M, Britto-Leon C. Understanding Impact of CFTR Dysfunction on Airway Immune Cell Composition in Early Lung Disease Pathogenesis. 2024, a6357-a6357. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6357.Peer-Reviewed Original ResearchCFTR Modulators Reprogram Sex-Specific Airway Neutrophil Signaling
Yin H, Kockar Kizilirmak T, Li N, Adams T, Sauler M, Gomez J, Britto-Leon C. CFTR Modulators Reprogram Sex-Specific Airway Neutrophil Signaling. 2024, a7454-a7454. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7454.Peer-Reviewed Original Research
2023
Hemoptysis in the Time of COVID
Kockar Kizilirmak T, Brumer E, Panacherry S, Egan M. Hemoptysis in the Time of COVID. 2023, a1928-a1928. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1928.Peer-Reviewed Original Research
2022
Ensuring Timely Pulmonary Follow Up After an Inpatient Asthma Hospitalization: A Quality Improvement Initiative
Brumer E, Cherian C, Godse S, Kockar Kizilirmak T, Grossman M, Chen L, Sheares B. Ensuring Timely Pulmonary Follow Up After an Inpatient Asthma Hospitalization: A Quality Improvement Initiative. 2022, a5722-a5722. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5722.Peer-Reviewed Original Research
2020
Low First Minute Apgar Scores Are Associated with Wheezing in Childhood
Kockar Kizilirmak T, Stern D, Guerra S, Wright A, Martinez F. Low First Minute Apgar Scores Are Associated with Wheezing in Childhood. 2020, a3697-a3697. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3697.Peer-Reviewed Original ResearchScreening for Latent Tuberculosis in Children With Immune-mediated Inflammatory Diseases Treated With Anti-tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests
Gİrİt S, Ayzit Atabek A, Şenol E, KoÇkar Kizilirmak T, Pekcan S, GÖktaŞ Ş, Öktem S, KasapÇopur Ö, ÇokuĞraŞ H. Screening for Latent Tuberculosis in Children With Immune-mediated Inflammatory Diseases Treated With Anti-tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests. Archives Of Rheumatology 2020, 35: 020-028. PMID: 32637916, PMCID: PMC7322294, DOI: 10.5606/archrheumatol.2020.7294.Peer-Reviewed Original ResearchCitationsAltmetricConceptsTuberculin skin testLatent tuberculosis infectionValues of TSTSixth monthT-SPOTSkin testInflammatory diseasesTuberculosis testAnti-tumor necrosis factor therapyAnti-tumor necrosis factor treatmentNecrosis factor therapyAnti-TNF agentsAnti-TNF therapyProspective multicentric studyNecrosis factor treatmentFactor therapyLatent tuberculosisTuberculin skinTuberculosis infectionMulticentric studyLocal guidelinesTB testFactor treatmentPatientsMonths